Tissue-based research in kidney cancer: current challenges and future directions (Q36982059)

17 August 2017

1 reference

title

Tissue-based research in kidney cancer: current challenges and future directions (English)

1 reference

17 August 2017

1 reference

5

0 references

Towia A Libermann

9

object named as

Towia Libermann

1 reference

17 August 2017

1

Sabina Signoretti

1 reference

17 August 2017

Gennady Bratslavsky

2

1 reference

17 August 2017

Frederick M Waldman

3

1 reference

17 August 2017

Victor E Reuter

4

1 reference

17 August 2017

Maria Merino

6

1 reference

17 August 2017

George V Thomas

7

1 reference

17 August 2017

Michael R Pins

8

1 reference

17 August 2017

John Gillespie

10

1 reference

17 August 2017

Joseph E Tomaszewski

11

1 reference

17 August 2017

Carolyn C Compton

12

1 reference

17 August 2017

Andrew Hruszkewycz

13

1 reference

17 August 2017

W Marston Linehan

14

1 reference

17 August 2017

Michael B Atkins

15

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 June 2008

1 reference

17 August 2017

Clinical Cancer Research

1 reference

17 August 2017

14

1 reference

17 August 2017

12

1 reference

17 August 2017

3699-3705

1 reference

Techniques, safety and accuracy of sampling of renal tumors by fine needle aspiration and core biopsy

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Novel targets and therapies for metastatic renal cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

The role of mammalian target of rapamycin inhibitors in the treatment of advanced renal cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Genomics of renal cell cancer: the biology behind and the therapy ahead

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Targeting von Hippel-Lindau pathway in renal cell carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

A genetic signature can predict prognosis and response to therapy in breast cancer: Oncotype DX.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

The pathology of renal epithelial neoplasms

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

2004 WHO classification of the renal tumors of the adults

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

The natural history of observed enhancing renal masses: meta-analysis and review of the world literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Technology insight: Identification of biomarkers with tissue microarray technology

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Prognostic factors for survival of patients with stage IV renal cell carcinoma: memorial sloan-kettering cancer center experience.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Validation of tissue microarray technology in breast carcinoma

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Fine-needle percutaneous biopsy of renal masses with helical CT guidance

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Prognostic significance of morphologic parameters in renal cell carcinoma.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Renal-cell carcinoma--molecular pathways and therapies.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Potential histologic and molecular predictors of response to temsirolimus in patients with advanced renal cell carcinoma

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Clinical response to therapy targeted at vascular endothelial growth factor in metastatic renal cell carcinoma: impact of patient characteristics and Von Hippel-Lindau gene status.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Biobanking of fresh frozen tissue: RNA is stable in nonfixed surgical specimens.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Long-term preservation of antigenicity on tissue microarrays

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2586673

Percutaneous biopsy of renal masses: sensitivity and negative predictive value stratified by clinical setting and size of masses

4 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18559586

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Gene signatures of progression and metastasis in renal cell cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18559586

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Trials probe new agents for kidney cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18559586

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1158/1078-0432.CCR-07-4733

1 reference

17 August 2017

1 reference

17 August 2017

1 reference